Influence of Year of Diagnosis, Patient Age, and Sociodemographic Status on Recommending Adjuvant Radiation Treatment for Stage I Testicular Seminoma
- 20 August 2008
- journal article
- genitourinary cancer
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 26 (24) , 3937-3942
- https://doi.org/10.1200/jco.2008.16.5043
Abstract
Adjuvant radiation therapy (ART) for stage I seminoma can cause adverse late effects and alternative postorchiectomy management strategies have been developed. This study evaluated ART trends in the United States and the impact of clinical and sociodemographic factors on ART recommendations. Of men diagnosed with stage I seminoma from 1990 through 2004, 3,125 were identified using the Surveillance, Epidemiology, and End Results cancer registry. A multivariable logistic regression analysis was performed to assess whether there was a significant association between diagnosis year, diagnosis age, race, county education level, region, tumor size, tumor category, and the recommendation for ART. There was a significant association (P < .001) between later year of diagnosis and a decrease in ART recommendation. Compared with men diagnosed in 1990 to 1994, men diagnosed in 1995 to 1999, and 2000 to 2004 were less likely to have ART (adjusted odds ratio [OR], 0.63; 95% CI, 0.48 to 0.84; and OR, 0.49; 95% CI, 0.37 to 0.63, respectively). There also was a significant association (P < .001) between county education level and ART recommendation. Men residing in counties with the highest education level were more likely to receive ART than men residing in counties with the lowest education level (OR, 2.12; 95% CI, 1.59 to 2.82). Also, men older than 30 years were more likely to receive ART than men age 30 or younger (OR, 1.26; 95% CI, 1.03 to 1.55). ART recommendations for stage I seminoma are declining. Men in less educated regions and the youngest men were less likely to receive a recommendation for ART.Keywords
This publication has 39 references indexed in Scilit:
- Treatment-Specific Risks of Second Malignancies and Cardiovascular Disease in 5-Year Survivors of Testicular CancerJournal of Clinical Oncology, 2007
- Evidence‐based guidelines for following stage 1 seminomaCancer, 2007
- Surveillance of stage I testicular seminoma: British Columbia Cancer Agency Experience 1992 to 2002Urology, 2006
- Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term SurvivorsJNCI Journal of the National Cancer Institute, 2005
- long-term follow-up of anglian germ cell cancer group surveillance versus patients with stage 1 nonseminoma treated with adjuvant chemotherapyUrology, 2004
- Mortality After Cure of Testicular SeminomaJournal of Clinical Oncology, 2004
- Cardiovascular Disease as a Long-Term Complication of Treatment for Testicular CancerJournal of Clinical Oncology, 2003
- Seminoma of the testis: is scrotal shielding necessary when radiotherapy is limited to the para-aortic nodes?Radiotherapy and Oncology, 1999
- Variations in breast cancer treatment by patient and provider characteristicsBreast Cancer Research and Treatment, 1996
- Surveillance following orchidectomy for stage I seminoma of the testisEuropean Journal Of Cancer, 1993